ARMO BioSciences Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ARMO BioSciences Inc. - overview
Established
2012
Location
Redwood City, CA, US
Primary Industry
Pharmaceuticals
About
Established in 2012 and based in California, US, ARMO BioSciences Inc. is a biopharmaceutical company that focuses on the development of novel proprietary products that activate the immune systems of cancer patients to recognize and eradicate tumors.
Current Investors
Kleiner Perkins, OrbiMed Advisors, DAG Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Specialty Pharmaceuticals
Website
www.armobio.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
ARMO BioSciences Inc. - financials
| Fiscal Year Ended | Dec 31, 2017 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
ARMO BioSciences Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.